|Bid||143.79 x 1000|
|Ask||143.86 x 800|
|Day's range||143.15 - 145.77|
|52-week range||94.34 - 145.87|
|Beta (5Y monthly)||0.41|
|PE ratio (TTM)||28.87|
|Earnings date||20 Oct 2020|
|Forward dividend & yield||3.16 (2.23%)|
|Ex-dividend date||22 Oct 2020|
|1y target est||141.69|
P&G's latest earnings underscore the ongoing impact of the COVID-19 pandemic.
It didn't take long for Procter & Gamble (NYSE: PG) to abandon its conservative fiscal 2021 outlook. Organic sales rose 9% in that period, marking an acceleration over the prior quarter's 6% increase. P&G's growth was led by higher sales volumes, but average prices also rose.